Amylyx Pharmaceuticals (AMLX) Stock Chart & Stock Price History $8.20 +0.52 (+6.77%) As of 12:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Amylyx Pharmaceuticals Stock Price Performance The Amylyx Pharmaceuticals (AMLX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 279.63%, with a year-to-date return of 116.93%. In the past month, the stock has increased 48.55%, reflecting recent market activity. As of the latest close, Amylyx Pharmaceuticals traded at $7.68 with a market cap of $684.60 million and volume of 1.68 million shares. Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+13.26%1 Month Performance+48.55%3 Month Performance+110.26%Year-To-Date Performance+116.93%1 Year Performance+279.63% AMLX Stock Chart for Monday, July, 14, 2025 AMLX Chart by TradingView Amylyx Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$7.39$7.68+3.92%$7.73$7.211.68 million shs$684.60 million07/10/2025$7.24$7.39+2.07%$7.61$7.131.58 million shs$658.75 million07/09/2025$6.98$7.24+3.72%$7.40$6.902.00 million shs$645.37 million07/08/2025$6.76$6.98+3.25%$7.00$6.572.24 million shs$622.20 million07/07/2025$6.30$6.76+7.30%$7.00$6.142.32 million shs$602.59 million07/04/2025$6.30$6.30$6.58$5.971.38 million shs$561.59 million07/03/2025$6.57$6.30-4.11%$6.58$5.971.38 million shs$561.58 million07/02/2025$6.41$6.57+2.50%$6.86$6.312.02 million shs$585.65 million07/01/2025$6.41$6.41$6.52$6.192.02 million shs$571.39 million06/30/2025$6.33$6.41+1.26%$6.57$6.262.13 million shs$571.39 million Get the Latest News and Ratings for AMLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$6.50$6.33-2.62%$6.59$6.0811.94 million shs$564.26 million06/26/2025$6.26$6.50+3.83%$6.56$6.231.17 million shs$579.41 million06/25/2025$6.41$6.26-2.34%$6.50$6.031.80 million shs$558.02 million06/24/2025$5.02$6.41+27.69%$6.70$5.314.21 million shs$571.39 million06/23/2025$5.05$5.02-0.59%$5.09$4.80822,649 shs$447.48 million06/20/2025$5.10$5.05-0.98%$5.15$4.861.38 million shs$450.16 million06/19/2025$5.10$5.10$5.28$5.02908,521 shs$454.61 million06/18/2025$5.33$5.10-4.32%$5.28$5.02908,521 shs$454.61 million06/17/2025$5.44$5.33-2.02%$5.66$5.31947,399 shs$475.12 million06/16/2025$5.52$5.44-1.45%$5.63$5.37938,592 shs$484.93 million06/13/2025$5.52$5.52$5.55$5.33890,299 shs$492.06 million Related Companies ImmunityBio Stock Chart Gemini Therapeutics Stock Chart Arrowhead Pharmaceuticals Stock Chart Apellis Pharmaceuticals Stock Chart NewAmsterdam Pharma Stock Chart Twist Bioscience Stock Chart Denali Therapeutics Stock Chart Kiniksa Pharmaceuticals International Stock Chart Agios Pharmaceuticals Stock Chart Recursion Pharmaceuticals Stock Chart Receive AMLX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Amylyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AMLX) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amylyx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amylyx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
